Antituberculosis therapy-induced liver injury: A case report and clinical management strategies
Year: 2024
Type: article
Abstract: Drug-Induced Liver Injury (DILI) from Anti-Tuberculosis Therapy (ATT) is increasingly common and affects patient outcomes. Factors like alcohol use, existing liver conditions, and gender (especially females) influence DILI risk. Recognizing and managing DILI quickly is crucial
Author: Sara Shreen
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4405457728
